Exophthalmos  >>  salmeterol xinafoate/fluticasone propionate (LIPO 102)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
salmeterol xinafoate/fluticasone propionate (LIPO 102) / Evofem Biosci
NCT00954057: Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)

Completed
2
11
RoW
LIPO-102, Placebo
Neothetics, Inc
Thyroid-Related Eye Disease
06/11
06/11

Download Options